Benefits of baked milk oral immunotherapy in French children with cow's milk allergy

Background Introduction and gradual incremental escalation of a low dose of baked milk may accelerate the resolution of severe cow's milk (CM) allergy for some children. The purpose of our study was to evaluate the efficacy and safety of baked milk oral immunotherapy (OIT) in children with CM allergy after a low‐dose baked milk oral food challenge (OFC). Methods In a retrospective analysis of OFC performed between 2013 and 2018 at the Children's Hospital of Toulouse (France), we identified 64 children with CM allergy and high milk and casein‐specific IgE levels, who underwent a total of 171 milk OFC. Mean age at 1st OFC was 4.8 years. Mean CM‐specific IgE was 47.9 kUA/L, and mean casein‐specific IgE was 42.3 kUA/L. Results Most children were treated with baked milk OIT. Our study shows that 67.2% of the children did not react to 1st low‐dose baked milk OFC (168.6 mg of CM protein). Eighteen percent of children stopped the OIT at home. Finally, desensitization to fresh milk was achieved in 27 children (42.2% of children allergic to CM). Children with lower CM‐specific IgE levels have a significantly higher probability of becoming desensitized to unbaked CM. Conclusion Most children with CM allergy and high milk and casein‐specific IgE levels tolerate the introduction of baked milk. However, the occurrence of anaphylactic reactions during OIT remains possible.